Table 2. General characteristics of the 99 patients included in the study with staging and grading of fibrosis an0064 necro-inflammatory activity, classified using the METAVIR scoring system.
| Factor | Clinical data |
|---|---|
| Male, ‘n’ (%) | 64 (64.60%) |
| Female, ‘n’ (%) | 35 (35.40%) |
| Age, years | 37.70±9.97 |
| BMI | 23.87±3.42 |
| LSM (kPa) | 7.06±1.85 |
| F1, ‘n’ (%) | 81 (81.80%) |
| F2, ‘n’ (%) | 18 (18.20%) |
| ALT(U/I) | 46.73±30.19 |
| AST(U/I) | 31.87±18.94 |
| TBIL(mmol/I) | 14.11±5.40 |
| DBIL(mmol/I) | 4.51±1.89 |
| Total number | 99 |
Notes: All the data are reported as statistical quantiles (percentage) or mean±standard deviation, as appropriate for the dataset. LSM: Liver stiffness measurement; BMI: body Mass Index; ALT: alanine transaminase; AST: aspartate aminotransferase; TBIL: total bilirubin; DBIL: direct bilirubin.